CollPlant Biotechnologies Ltd
CLGN- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001631487
No open-market purchases or sales by CollPlant Biotechnologies Ltd insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $582.4K in total; no superinvestor holds it.
13F holders, Q1 2021
Institutional positions in CollPlant Biotechnologies Ltd as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- No complete 13F data for Q4 2020
- Shares held
- 1.81M
- No complete 13F data for Q4 2020
- Total value
- $24.4M
- No complete 13F data for Q4 2020
Holders and value by quarter
Institutions reporting CLGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 16 | $582.4K |
| Q1 2026 | 21 | $819.0K |
| Q4 2025 | 17 | $1.93M |
| Q3 2025 | 19 | $4.08M |
| Q2 2025 | 18 | $2.53M |
| Q1 2025 | 16 | $3.33M |
| Q4 2024 | 14 | $4.59M |
| Q3 2024 | 13 | $6.79M |
| Q2 2024 | 16 | $7.39M |
| Q1 2024 | 13 | $7.59M |
| Q4 2023 | 17 | $9.14M |
| Q3 2023 | 18 | $8.55M |
| Q2 2023 | 17 | $12.5M |
| Q1 2023 | 18 | $10.9M |
| Q4 2022 | 18 | $13.1M |
| Q3 2022 | 21 | $10.7M |
| Q2 2022 | 20 | $14.3M |
| Q1 2022 | 16 | $19.5M |
| Q4 2021 | 21 | $29.5M |
| Q3 2021 | 15 | $33.1M |
| Q2 2021 | 16 | $51.9M |
| Q1 2021 | 15 | $24.4M |
Institutions, Q1 2021
Shares, value and share of portfolio for each institution holding CollPlant Biotechnologies Ltd.
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Meitav Dash Investments Ltd | 547,730 | $7.36M | 0.24% | – | – |
| Investment Management of Virginia LLC | 530,400 | $7.13M | 1.44% | – | – |
| Friess Associates LLC | 250,091 | $3.36M | 1.31% | – | – |
| Villere St Denis J & Co LLC | 242,250 | $3.25M | 0.18% | – | – |
| Benjamin F. Edwards & Company, Inc. | 69,820 | $938.0K | 0.05% | – | – |
| Brown Advisory Inc | 54,650 | $734.0K | 0.00% | – | – |
| Weil Company, Inc. | 34,968 | $470.0K | 0.27% | – | – |
| Raymond James & Associates | 20,800 | $280.0K | 0.00% | – | – |
| Sigma Planning Corp | 19,700 | $265.0K | 0.01% | – | – |
| Sabby Management, LLC | 17,045 | $229.0K | 0.17% | – | – |
| Royal Bank of Canada | 10,000 | $134.0K | 0.00% | – | – |
| FNY Investment Advisers, LLC | 10,000 | $134.0K | 0.05% | – | – |
| Parallel Advisors, LLC | 5,122 | $69.0K | 0.00% | – | – |
| UBS Group AG | 1,178 | $16.0K | 0.00% | – | – |
| Sandy Spring Bank | 117 | $2.00K | 0.00% | – | – |